Last edition
News about Global Pharma
Nordic Bioscience Introduces Novel Endotrophin Assay
Nordic Bioscience has launched nordicEndotrophin, a fully automated, high-precision assay that quantifies the intact 77-amino-acid Endotrophin hormone, enhancing risk stratification and treatment monitoring in fibrosis, cancer, and chronic diseases.
Global Pharma | 16/05/2025 | By Manvi | 177
Senores Pharmaceuticals Reports 174 Percent Revenue Growth in Emerging Markets in FY25
Senores Pharmaceuticals Ltd. reported a robust 69 percent year-on-year growth in regulated market revenue to INR 244.8 crore in FY25, alongside a 174 percent surge in emerging market revenue, reflecting strong momentum across its global pharmaceutical operations.
Global Pharma | 16/05/2025 | By Manvi | 443
Wesper Revolutionizes Sleep Apnea Diagnosis with FDA-Cleared, Cannula-Free Technology
Without capturing this core signal, critical events like hypopneas can be missed, misclassified, or misunderstood. As clinical research and expert consensus increasingly affirm, airflow isn't optional—it's essential.
Global Pharma | 16/05/2025 | By Manvi | 336
Marksans Pharma's UK Subsidiary Relonchem Secures Marketing Authorisation for Gabapentin from UKMHRA
Relonchem Ltd. has received marketing authorisation for its product Gabapentin 50 mg/ml oral solution.
Global Pharma | 15/05/2025 | By Manvi | 286
Sanofi to Invest USD 20 Billion in US by 2030 to Expand R&D and Manufacturing
Sanofi has announced plans to invest at least $20 billion in the United States by 2030, significantly boosting R&D and manufacturing to support the launch of new therapies and strengthen the domestic supply chain.
Global Pharma | 15/05/2025 | By Manvi | 204
Genesys Spine Launches Stasys-C 3DP, a Zero-Profile 3D-Printed Cervical Standalone System
Genesys Spine has announced the commercial launch of the Stasys-C™ 3DP Cervical Standalone System, a 3D-printed, zero-profile cervical interbody solution designed to simplify anterior cervical procedures while promoting early fusion.
Global Pharma | 15/05/2025 | By Manvi | 211
Cariflex Inaugurates World's Largest Polyisoprene Latex Plant in Singapore
With an investment of USD 355 million, the plant is the largest of its kind in the world and will significantly expand Cariflex's production capacity to meet the growing demand for high-quality synthetic latex for medical and protective applications.
Global Pharma | 15/05/2025 | By Manvi | 518
Standard Glass Lining Technology (SGLTL) in collaboration with Japan’s AGI Group and its affiliate GL HAKKO will manufacture glass-lined shell and tube heat exchangers in India. The production is estimated to commence by Q4, FY26.
Global Pharma | 14/05/2025 | By Manvi | 1082
Zydus Secures EIR from USFDA for Ambernath API Manufacturing Facility
Zydus Lifesciences has received an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA). The EIR has been classified under the no action indicated (NAI) category.
Global Pharma | 14/05/2025 | By Manvi | 637
USFDA Completes Inspection at Solara's Ambernath Facility with Zero Form 483 Observations
Solara Active Pharma Sciences Ltd. announced that its Ambernath API manufacturing facility has successfully completed a USFDA inspection with zero Form 483 observations, confirming the site’s compliance with regulatory standards.
Global Pharma | 14/05/2025 | By Manvi | 608
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy